(LIN) Linde Ordinary Shares - Ratings and Ratios
Oxygen, Nitrogen, Argon, Hydrogen, Helium, Carbon Dioxide
LIN EPS (Earnings per Share)
LIN Revenue
Description: LIN Linde Ordinary Shares
Linde plc is a leading industrial gas company operating globally, with a presence in key regions including the United States, China, Germany, the United Kingdom, Australia, Mexico, and Brazil. The company provides a broad portfolio of products, including atmospheric gases (oxygen, nitrogen, argon, and rare gases) and process gases (hydrogen, helium, carbon dioxide, etc.), catering to diverse industries such as healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics.
The companys business model extends beyond gas production, as it also designs and constructs turnkey process plants for both third-party customers and its own gas businesses. These plants encompass various technologies, including air separation, hydrogen, synthesis, olefin, and natural gas plants, showcasing Lindes capabilities in engineering and project execution. With a history dating back to 1879, Linde has established itself as a veteran player in the industrial gases sector.
From a financial perspective, Linde plc exhibits strong performance indicators. The companys Return on Equity (RoE) stands at 17.23%, indicating efficient use of shareholder capital. Additionally, the dividend yield, although not explicitly mentioned, is an important metric for income-focused investors. Lindes global presence and diversified customer base across various industries contribute to its stability and growth prospects. Key Performance Indicators (KPIs) such as revenue growth, EBITDA margins, and debt-to-equity ratio are crucial in assessing the companys financial health and operational efficiency. For instance, a high EBITDA margin would suggest strong operational profitability, while a manageable debt-to-equity ratio would indicate a healthy capital structure.
To further evaluate Lindes investment potential, its essential to consider industry trends, competitive positioning, and growth drivers. The industrial gases market is expected to grow due to increasing demand from emerging economies and the need for cleaner energy solutions. Lindes ability to innovate and expand its product offerings, as well as its capacity to execute large-scale projects, will be critical in maintaining its market share and driving future growth. Investors should monitor KPIs such as the companys market share, new project wins, and R&D investments to gauge its competitiveness and growth prospects.
LIN Stock Overview
Market Cap in USD | 223,028m |
Sub-Industry | Industrial Gases |
IPO / Inception | 2002-01-11 |
LIN Stock Ratings
Growth Rating | 59.1% |
Fundamental | 69.3% |
Dividend Rating | 65.3% |
Return 12m vs S&P 500 | -12.3% |
Analyst Rating | 4.0 of 5 |
LIN Dividends
Dividend Yield 12m | 1.55% |
Yield on Cost 5y | 3.13% |
Annual Growth 5y | 7.62% |
Payout Consistency | 100.0% |
Payout Ratio | 38.0% |
LIN Growth Ratios
Growth Correlation 3m | 51.3% |
Growth Correlation 12m | 23.2% |
Growth Correlation 5y | 94.7% |
CAGR 5y | 15.74% |
CAGR/Max DD 5y | 0.69 |
Sharpe Ratio 12m | 0.67 |
Alpha | -6.81 |
Beta | 0.466 |
Volatility | 13.48% |
Current Volume | 2579.2k |
Average Volume 20d | 1545.5k |
Stop Loss | 467.6 (-3%) |
Signal | 1.01 |
Piotroski VR‑10 (Strict, 0-10) 6.5
Net Income (6.71b TTM) > 0 and > 6% of Revenue (6% = 1.99b TTM) |
FCFTA 0.06 (>2.0%) and ΔFCFTA -0.16pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -3.27% (prev -2.01%; Δ -1.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.12 (>3.0%) and CFO 9.91b > Net Income 6.71b (YES >=105%, WARN >=100%) |
Net Debt (21.13b) to EBITDA (12.88b) ratio: 1.64 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.93 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (473.6m) change vs 12m ago -1.99% (target <= -2.0% for YES) |
Gross Margin 40.08% (prev 35.94%; Δ 4.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 39.98% (prev 40.92%; Δ -0.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 21.43 (EBITDA TTM 12.88b / Interest Expense TTM 427.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.40
(A) -0.01 = (Total Current Assets 13.63b - Total Current Liabilities 14.71b) / Total Assets 86.08b |
(B) 0.17 = Retained Earnings (Balance) 14.60b / Total Assets 86.08b |
(C) 0.11 = EBIT TTM 9.15b / Avg Total Assets 83.15b |
(D) 0.18 = Book Value of Equity 8.35b / Total Liabilities 46.09b |
Total Rating: 1.40 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.28
1. Piotroski 6.50pt = 1.50 |
2. FCF Yield 2.08% = 1.04 |
3. FCF Margin 15.25% = 3.81 |
4. Debt/Equity 0.67 = 2.28 |
5. Debt/Ebitda 2.01 = -0.03 |
6. ROIC - WACC 4.45% = 5.57 |
7. RoE 17.46% = 1.46 |
8. Rev. Trend 1.83% = 0.09 |
9. Rev. CAGR -1.26% = -0.21 |
10. EPS Trend 90.74% = 2.27 |
11. EPS CAGR 14.98% = 1.50 |
What is the price of LIN shares?
Over the past week, the price has changed by +0.30%, over one month by +3.14%, over three months by +4.58% and over the past year by +3.25%.
Is Linde Ordinary Shares a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LIN is around 499.05 USD . This means that LIN is currently overvalued and has a potential downside of 3.51%.
Is LIN a buy, sell or hold?
- Strong Buy: 12
- Buy: 6
- Hold: 9
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the LIN price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 505.6 | 4.9% |
Analysts Target Price | 491.5 | 1.9% |
ValueRay Target Price | 548.7 | 13.8% |
Last update: 2025-08-15 02:51
LIN Fundamental Data Overview
CCE Cash And Equivalents = 4.79b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 33.8527
P/E Forward = 28.9017
P/S = 6.7086
P/B = 5.7907
P/EG = 2.4297
Beta = 0.929
Revenue TTM = 33.24b USD
EBIT TTM = 9.15b USD
EBITDA TTM = 12.88b USD
Long Term Debt = 19.70b USD (from longTermDebt, last quarter)
Short Term Debt = 6.22b USD (from shortTermDebt, last quarter)
Debt = 25.92b USD (Calculated: Short Term 6.22b + Long Term 19.70b)
Net Debt = 21.13b USD (from netDebt column, last quarter)
Enterprise Value = 244.16b USD (223.03b + Debt 25.92b - CCE 4.79b)
Interest Coverage Ratio = 21.43 (Ebit TTM 9.15b / Interest Expense TTM 427.0m)
FCF Yield = 2.08% (FCF TTM 5.07b / Enterprise Value 244.16b)
FCF Margin = 15.25% (FCF TTM 5.07b / Revenue TTM 33.24b)
Net Margin = 20.20% (Net Income TTM 6.71b / Revenue TTM 33.24b)
Gross Margin = 40.08% ((Revenue TTM 33.24b - Cost of Revenue TTM 19.92b) / Revenue TTM)
Tobins Q-Ratio = 29.25 (Enterprise Value 244.16b / Book Value Of Equity 8.35b)
Interest Expense / Debt = 0.26% (Interest Expense 67.0m / Debt 25.92b)
Taxrate = 22.91% (from yearly Income Tax Expense: 2.00b / 8.74b)
NOPAT = 7.05b (EBIT 9.15b * (1 - 22.91%))
Current Ratio = 0.93 (Total Current Assets 13.63b / Total Current Liabilities 14.71b)
Debt / Equity = 0.67 (Debt 25.92b / last Quarter total Stockholder Equity 38.52b)
Debt / EBITDA = 2.01 (Net Debt 21.13b / EBITDA 12.88b)
Debt / FCF = 5.11 (Debt 25.92b / FCF TTM 5.07b)
Total Stockholder Equity = 38.45b (last 4 quarters mean)
RoA = 7.80% (Net Income 6.71b, Total Assets 86.08b )
RoE = 17.46% (Net Income TTM 6.71b / Total Stockholder Equity 38.45b)
RoCE = 15.74% (Ebit 9.15b / (Equity 38.45b + L.T.Debt 19.70b))
RoIC = 11.40% (NOPAT 7.05b / Invested Capital 61.88b)
WACC = 6.95% (E(223.03b)/V(248.95b) * Re(7.73%)) + (D(25.92b)/V(248.95b) * Rd(0.26%) * (1-Tc(0.23)))
Shares Correlation 5-Years: -100.0 | Cagr: -2.14%
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 77.14% ; FCFE base≈4.98b ; Y1≈4.62b ; Y5≈4.22b
Fair Price DCF = 161.4 (DCF Value 75.70b / Shares Outstanding 468.9m; 5y FCF grow -9.18% → 3.0% )
Revenue Correlation: 1.83 | Revenue CAGR: -1.26%
Rev Growth-of-Growth: 2.49
EPS Correlation: 90.74 | EPS CAGR: 14.98%
EPS Growth-of-Growth: -7.50
Additional Sources for LIN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle